secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2022-11-21T23:59:59+00:00
Accession:  0001493152-22-033115
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics receives Nasdaq delisting notice for bid price non-compliance
----------------------------------------------------------------------------

- Received Nasdaq notice on Nov 17, 2022: common stock closing bid below $1.00 for 30 consecutive business days.
- Compliance period of 180 calendar days until May 16, 2023 to regain minimum $1.00 bid price.
- May qualify for second 180-day period if meeting other listing standards and notifying Nasdaq of intent to cure.
- Company plans to assess potential actions but may be unable to regain compliance and face delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315222033115/0001493152-22-033115-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315222033115/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-033115

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer